-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$51.6833.4% Upside
Recent Analyst Forecasts and Stock Ratings
Ionis Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Ionis Pharmaceuticals, Inc.?
Ionis Pharmaceuticals, Inc. has been rated by research analysts at Guggenheim, BMO Capital, Leerink Partners, Jefferies, Goldman Sachs, Stifel Nicolaus in the past 90 days.